表观遗传疗法:将三阴性乳腺癌重新编程成响应的亚型
Endocrine-related cancer
|July 10, 2025
概括
三阴性乳腺癌 (TNBC) 是具有侵略性的. 表观遗传药物可以将TNBC细胞重新编程成不太具有攻击性的亚型,从而提高治疗效率和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种缺乏向治疗的攻击性亚型.
- TNBC表现出高可塑性,有助于治疗挑战.
- 表观遗传机制,包括DNA甲基化和基因组修饰,都与TNBC的进展有关.
研究的目的:
- 审查表观遗传调制在TNBC亚型转换中的作用.
- 探索表观遗传药物 (表观药物) 在增强TNBC治疗方面的潜力.
- 讨论使用TNBC的流行病药物的挑战和局限性.
主要方法:
- 对TNBC中的表观遗传机制现有文献的审查.
- 分析表观遗传药物如何向DNA甲基转移酶和基因素修饰剂等酶.
- 讨论TNBC可塑性和亚型重编程策略.
主要成果:
- 表观遗传调节可以将TNBC重新编程成不那么具有攻击性,更易于治疗的亚型.
- 流行药物可以使TNBC细胞对激素治疗和化疗等常规疗法重新敏感.
- 通过表观遗传学利用TNBC可塑性提供了一个新的治疗途径.
结论:
- 表观遗传重编程是治疗侵袭性TNBC的一个有前途的策略.
- 传染病药物有可能为个性化和有效的TNBC疗法提供潜力.
- 需要进一步的研究,以解决局限性问题,并优化TNBC治疗中的冠状腺癌药物使用.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
920
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
